News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD
Tuesday, April 11, 2023Verona Pharma plc a clinicalstage biopharmaceutical company focused on respiratory diseases announces its development partner Nuance Pharma has dosed the first subject in its ENHANCE China Phase trial for the maintenance treatment of chronic obstru...
SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices
Tuesday, April 11, 2023SK Biopharmaceuticals an innovative global pharmaceuticals company announced that its digital wearable devices Zero WiredTM and Zero EarbudsTM have won the Red Dot Design Award in the healthcare category for outstanding design The Red Dot Design A...
Charlotte's Web forms Joint Venture with BAT and AJNA BioSciences to Seek FDA-Approval for Proprietary Full Spectrum Hemp Extract Botanical Drug
Friday, April 07, 2023Charlottes Web Holdings Inc the market leader in fullspectrum hemp extract wellness products today announced it has formed a joint venture the JV with AJNA BioSciences PBC AJNA a botanical drug development company focused on mental health and neurolo...
Vistagen Receives New European Patent for AV-101
Thursday, April 06, 2023Vistagen a late clinicalstage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety depression and other central nervous system CNS disorders today announced that the European Patent Office EPO has...
Horus Pharma Group Launches a Nordic Subsidiary
Thursday, April 06, 2023Horus Pharma an independent French laboratory specialised in ophthalmology has taken a major step in its European expansion strategy with the opening of its new subsidiary From its base in Stockholm Sweden Horus Pharma Nordic will cover Sweden Norway...
Forcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline Therapeutics
Wednesday, April 05, 2023Forcefield Therapeutics Ltd a pioneer of bestinclass therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction and Freeline Therapeutics have entered into an exclusive patent and knowhow license ag...
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
Wednesday, April 05, 2023InflaRx NV a clinicalstage biopharmaceutical company developing antiinflammatory therapeutics by targeting the complement system today announced that Gohibic vilobelimab a firstinclass monoclonal antihuman complement factor Ca antibody has been grant...
Sandoz receives approval by European Commission for Hyrimoz® (adalimumab) high-concentration formulation
Tuesday, April 04, 2023Sandoz a global leader in offpatent generic and biosimilar medicines today announced that the European Commission EC granted marketing authorization in the European Union EU for a citratefree high concentration formulation HCF mgmL of its biosimilar...
Medigene enters Cooperative Research and Development Agreement with the National Cancer Institute to evaluate the use of Medigene’s proprietary T cell receptors in novel cell constructs
Tuesday, April 04, 2023Medigene AG an early stage immunooncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors and the National Cancer Institute NCI will collaborate to evaluate the potential of Medigenes proprietary...
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
Saturday, April 01, 2023Ablaze Pharmaceuticals a biotech company that is focused on developing Targeted Radiotherapy TRT to benefit cancer patients in China today announced the development plans of a firstinclass novel peptide drug candidate against GPC The proprietary GPC...
